DCM
ORIC icon

Driehaus Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Driehaus Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-148,778
Closed -$1.79M – 460
2025
Q3 		$1.79M Buy
+148,778
New +$1.57M 0.01% 355
2024
Q4 		– Sell
-119,083
Closed -$1.22M – 437
2024
Q3 		$1.22M Sell
119,083
-24,860
-17% -$246K 0.01% 313
2024
Q2 		$1.02M Hold
143,943
– – 0.01% 309
2024
Q1 		$1.98M Hold
143,943
– – 0.02% 307
2023
Q4 		$1.32M Hold
143,943
– – 0.02% 307
2023
Q3 		$871K Buy
+143,943
New +$1.18M 0.01% 332

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Driehaus Capital Management's ORIC Position: Q4 2025 in Review

Driehaus Capital Management sold out of Oric Pharmaceuticals (ORIC) in Q4 2025, closing a stake of 148,778 shares — an estimated $1.79M sold.

Driehaus Capital Management first reported a position in ORIC in Q3 2023 and held it in 6 quarters. The position peaked at $1.98M in Q1 2024. 164 funds tracked by Wall St. Rank hold ORIC as of Q4 2025.

  • Driehaus Capital Management reported no remaining Oric Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 148,778 Oric Pharmaceuticals shares in Q4 2025, an estimated $1.79M.
  • Driehaus Capital Management first reported a position in Oric Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Driehaus Capital Management's Oric Pharmaceuticals position peaked at $1.98M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2025.

Based on Driehaus Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.